About Meet the CAMP Team

Mark is an Associate Professor in the Department of Epidemiology and Biostatistics at University at Albany’s School of Public Health. He is a co-investigator on the Multicenter AIDS Cohort Study/Women’s Interagency HIV Study Combined Cohort Study (MACS/WIHS CCS), Central Africa International Epidemiology Databases to Evaluate AIDS (CA-IeDEA), and a training grant entitled Strategic Training Partnership to End AIDS in Georgia. Mark teaches epidemiology methods, as well as AIDS epidemiology and Infectious Diseases epidemiology at the University at Albany, and supervises masters and doctoral public health students. Research interests include immune system and immunogenetic epidemiology, longitudinal and mediation analyses, implementation science, HIV/AIDS, viral hepatitis (A to E), cardiovascular disease, liver disease and aging.

Montserrat is a PhD student in the Department of Public Administration and Policy at the Rockefeller College of Public Affairs and Policy at the University at Albany. Her concentration is Public Policy. Prior to her doctoral studies, Montserrat completed her MA in Economics at Penn State and worked for several years doing research on topics like poverty and education at the World Bank. She is interested in the use of advanced quantitative methods to solve relevant public policy issues. She currently works as a PhD student data analyst on the CAMP project.

John Angles is a Ph.D. student pursuing a degree in biostatistics at the University at Albany, State University of New York. Prior to his doctoral studies, he completed his MPH with a concentration in Data Analytics from SUNY Upstate Medical University. He works as a Ph.D. student data analyst on the CAMP project.

Dr. Rachel Hart-Malloy is the Director of the Office of Sexual Health and Epidemiology, at the New York State Health Department’s AIDS Institute, and is an Assistant Professor at the University at Albany, School of Public Health, Department of Epidemiology and Biostatistics. Her predominate research and applied public health experience has focused on sexually transmitted infections (STIs), HIV, and Hepatitis C virus (HCV) epidemiology, surveillance, evaluation, policy and programming.

Dr. Erika Martin is an associate professor in the Department of Public Administration and Policy at the University at Albany’s Rockefeller College of Public Affairs and Policy. As an applied health policy and public health systems researcher, she uses mixed methods to evaluate the adoption and impact of public health policies and allocation of scarce public health resources, with a focus on HIV/AIDS. She also studies the sustainability and impact of open health data initiatives. She has considerable experience collaborating with government agency staff to translate rigorous evidence-based research into public health practice.

Arzana Myderrizi is a PhD student in the Department of Public Administration and Policy at the Rockefeller College of Public Affairs and Policy at the University at Albany. Prior to her doctoral studies, she completed her MA in Economics from Vanderbilt University. Her broad research interests include applying economic theories and tools to evaluate the impact of public policies. She has several years of experience in quantitative research and evaluation in the US and abroad. She works as a PhD student data analyst on the CAMP project.

Dr. Rosenberg is Deputy Director for Science in the Office of Public Health, at the New York State Department of Health. He is also Associate Professor in the Department of Epidemiology and Biostatistics at the University at Albany School of Public Health. Rosenberg helped to lead CAMP as co-PI and PI from 2014-2021.

Heather Bradley is an Associate Professor of Epidemiology at Emory’s Rollins School of Public Health. She is an infectious disease epidemiologist whose main research interests include surveillance methodology, racial disparities in HIV and hepatitis C infections, and the intersection of infectious diseases with the U.S. opioid epidemic. During the past few years, her research has focused largely on racial disparities in COVID-19 outcomes. Before joining Emory, she served on the faculty at Georgia State University School of Public Health. Prior to that appointment, she spent eight years at the Centers for Disease Control and Prevention in positions ranging from Epidemic Intelligence Service (EIS) Officer to Associate Chief for Science in the Division of HIV/AIDS Prevention.

Monica Trigg is a Director of Programs in the Department of Epidemiology. Before joining Emory in 2013, Monica supported a number of global health initiatives with CARE, The Carter Center, and the Peace Corps. These roles took her on many incredible adventures across the world and provided exposure and built expertise in real-world public health concerns and programs through which to address them. She also spent five years with the Georgia Department of Public Health with the Immunization Program, first as a regional program officer and then as the Vaccine Manager, overseeing distribution of federally-purchased vaccine to the state’s 1,500+ immunization providers. Monica is currently pursuing a Doctorate in Public Health with the University of South Florida.

Anastasia Carter is an Associate Director of research Projects at Emory’s Rollins School of Public Health. She currently manages day-to-day operations for research projects related to people who inject drugs and COVID-19-related outcomes. Before joining Emory, she coordinated activities for clinical studies focusing on genetic risk factors of autism spectrum disorder and understanding characteristics of chromosome disorders at Children’s Healthcare of Atlanta. Prior to this, she assisted with participant engagement and recruitment among underrepresented populations in research at Morehouse School of Medicine.

Samuel Jenness is an Associate Professor in the Department of Epidemiology. He is the Principal Investigator of the EpiModel Research Lab, which uses epidemiological and economic modeling approaches to understand the etiology of and prevention strategies for sexually transmitted and respiratory infectious diseases. Recent studies have investigated the co-circulation of multiple infectious pathogens and optimizing the scale-up of prevention interventions to reduce health disparities. His methodological research has led to the development of an open-source software platform, EpiModel, which allows users to build and simulate data-driven mechanistic models for infectious disease dynamics that integrate network science methodologies.

Jalissa Shealey is an Associate Director of Research Projects at Emory Rollins School of Public Health. Her research focuses on improving surveillance systems among underrepresented populations. At the height of the COVID-19 pandemic, she led a team of qualitative researchers to interview over 50 non-responding racial minority households in a national seroprevalence study estimating the prevalence of the disease. Following her work on COVIDVu, she served as the Project Director for Represent ATL, a $1.3 million NIH-funded grant aimed at understanding the barriers and motivators Black and African American communities face when participating in COVID-19 testing and research. Currently, Jalissa is leading a systematic review and meta-analysis to quantify the burden of overdose among people who inject drugs (PWID); a population often underrepresented in surveillance.

Dr. Sullivan is a Professor in the Department of Epidemiology and has 20 years of experience in infectious disease epidemiology, mostly focused on the use of information from public health data systems to improve responses to the US HIV epidemic. In his work as an EIS officer, an epidemiologist, and a manager in CDC’s Division of HIV/AIDS Prevention, he has supported state and local health departments in the implementation and interpretation of surveillance and programmatic data. At CDC, he served as Chief of the Behavioral and Clinical Surveillance Branch, Acting Chief of the HIV Incidence and Case Surveillance Branch, and Acting DHAP Deputy Director for Science. He has published >150 manuscripts, including several high-impact models, was a Deputy Editor of Public Health Reports, and currently serves on the boards of PLoS ONE and Annals of Epidemiology. Sullivan is the co-director of the Center for AIDS Research Prevention Core, coordinating dissemination of prevention technologies and HIV prevention training/technical assistance.

Sourya Shrestha is a Research Associate in the department of Epidemiology at the Johns Hopkins Bloomberg School of Health. He received his doctoral training in applied mathematics from the University of Michigan, and postdoctoral training in ecology and epidemiology of infectious diseases at Michigan and Hopkins, respectively. He is interested in developing mathematical and computational models of epidemiology of infectious diseases, and to ultimately use them to design and inform effective public health interventions. Although he maintains interest in the epidemiology of pneumococcus and dengue virus, tuberculosis (TB) is the primary focus of his current research. Some of his recent and ongoing work includes (i) understanding the heterogeneity of TB in the context of targeted interventions; (ii) modeling dynamics and control of domestic TB in the US (in collaboration with the CDC); and (iii) developing models to inform active case finding efforts in Pakistan and Bangladesh (in collaboration with IRD), and in Nepal (in collaboration with IMPACT TB team).

Dr. Dowdy is an Assistant Professor of Epidemiology, practicing general internist, leader in the field of TB and TB/HIV modeling, and Director of the Johns Hopkins Tuberculosis Modeling Group. His expertise combines operational/implementation research, epidemiology, health economics, and mathematical modeling. He has published >75 peer-reviewed manuscripts, constructed >10 economic models of interventions to fight TB and TB/HIV and has interests in constructing models that account for local distribution of disease, as well as user-friendly models that can be accessed by public health decision-makers. He , won the International Union Against TB and Lung Disease’s Young Investigator Award in 2012 and leads twice-monthly conference calls (>100 group members) that highlight the importance of linkages between TB modelers and public health practitioners (podcasts available at modeltb.org), which include participants from the CDC and local health departments.

Lucia is a post-doctoral fellow in the Department of Epidemiology at Johns Hopkins Bloomberg School of Public Health. She has earned her PhD in Epidemiology from Imperial College London in 2020, working on modelling the impact of active case-finding interventions for TB in high burden settings, with a focus on India. Her research interests are focused on using mathematical modelling and cost-effectiveness to inform health programs and interventions, as well as policy. At Hopkins, she is involved in projects looking to integrate care across different infectious disease (in collaboration with the CDC), address disparities in TB disease, and model the impact of synergistic interventions to achieve greater reduction of TB incidence (in collaboration with CHAI).

Jeff began programming at an early age and has used his skills as a problem solving tool for more than 20 years. After joining the Johns Hopkins team in 2014, he began to explore the disease modeling space through different projects and discovered a new set of problems to which he can apply his knowledge. His areas of interest include systems and parallel programming, novel web-based UI's and program optimization

Kevin Maloney is an Assistant Professor of Epidemiology in the Department of Population Health Sciences at Georgia State University. His research includes mathematical modeling of infectious disease transmission dynamics, including HIV and other sexually transmitted infections among men who have sex with men. His work focuses on the individual and network level factors facilitating disease transmission and risk. Prior to joining the faculty at GSU, he completed a PhD in Epidemiology at Emory University. At GSU, he teaches graduate courses in infectious disease epidemiology and epidemiologic methods.

Eric Hall is an assistant professor of epidemiology at the Oregon Health & Science University-Portland State University School of Public Health, where he teaches methodological and substantive graduate-level courses in the epidemiology and public health practice programs. His research focuses on the development and utilization of epidemiologic, statistical and economic evaluation methods to provide data that have a direct implication on public health programs or policy. His ongoing work leverages models to quantify the disease burden of viral hepatitis and evaluate the cost-effectiveness of hepatitis B vaccination and hepatitis C screening policies.

Coming Soon!

Dr. Hamilton is a research scientist in the Center for Studies in Demography and Ecology at the University of Washington. He has been conducting research in the HIV/STI field for over 15 years in both the US and Africa with a focus on the evaluation of prevention interventions including voluntary medical male circumcision, home-based testing, RNA testing and pre-exposure prophylaxis. Dr. Hamilton specializes in statistical methods and mathematical modeling approaches to HIV/STI prevention research. As a member of CAMP Dr. Hamilton has developed network-based mathematical models of HIV transmission among adolescent populations.

Mike Barry, MPH (he/him) is a second-year doctoral student in the Department of Epidemiology at the University of Washington School of Public Health. His dissertation work aims to characterize methamphetamine use among cisgender men and transgender people who have sex with men, identify predictors of such use, and inform multi-pronged interventions in the methamphetamine use crisis. He centers perspectives of individuals from that community with lived experience using the drug, incorporating a Community-Based Participatory Research approach in his work. In 2021, prior to enrolling in the PhD program, Mike earned his MPH from UW. His work before graduate school includes serving as a Disease Intervention Specialist and later Epidemiologist in the HIV/STD Program at Public Health – Seattle & King County, and as a HIV Prevention Navigator at Cascade AIDS Project in Portland, OR before that. He holds a B.A. in cultural anthropology and a B.S. in journalism from Boston University, discovering his passion for HIV prevention work and LGBTQ+ social issues while interning at Partners In Health and the GLBTQ Domestic Violence Project (both in Boston, MA) as an undergraduate student. Mike is originally from the Boston Area but has called the Pacific Northwest home since 2014.

Steven Goodreau, PhD, is a Professor of Biological Anthropology and Adjunct Professor of Epidemiology at the University of Washington, where he has been since 2001. Coming of age as a gay man during the early years of the HIV epidemic, Steve combines his academic loves of mathematics, biology, and demography with his life experience to study the sexual networks of gay, bi, and other men who have sex with men. As part of the statnet and EpiModel teams, he has co-developed many methods and tools to collect, analyze and simulate dynamic sexual networks and the pathogens that spread within them. He has applied these methods to a wide range of questions about the origin and reduction of HIV and STD disparities and the impact of both behavioral and biomedical interventions. He has also conducted work on HIV evolution, on HIV and STDs in other populations, and, most recently, on pregnancy declines in US adolescents. He has been a member of Team CAMP since 2015. A native of the underappreciated State of Rhode Island, Steve fulfilled a life dream in late February 2020 when, just days before lockdown, he appeared on Jeopardy! with the late, great Alex Trebek. He loves dogs, running, and transit-based urban exploration.

Dr. Katz is an Acting Instructor in the Department of Medicine at the University of Washington and an Epidemiologist for the Public Health – Seattle & King County HIV/STD Program. His research and public health practice activities focus on HIV/STD partner services, HIV self-testing, and mathematical modeling of HIV prevention strategies for gay, bisexual, and other men who have sex with men. He also serves as a consultant to the World Health Organization Department of HIV/AIDS on HIV testing services.

Dr. Kelly is the Assistant State Epidemiologist at the SC Department of Health and Environmental Control. Dr. Kelly has over 35 years of clinical and public health experience in HIV, STI, and TB at the local, state and federal levels, including as a medical officer in the DHAP HIV Incidence and Case Surveillance Branch, Director of the HIV/AIDS Epidemiology Unit in the Georgia Department of Public Health, and as a Tuberculosis Control Officer with Indian Health Service (IHS).

Michelle L. Allen currently serves as the Infection Section Director for the Georgia Department of Public Health. Ms. Allen presently oversees Program Collaboration and Service Integration initiatives. Ms. Allen assists in the development of policies and procedures and directs planning and operational activities. Ms. Allen is a champion for public health as she continually strives to move the Georgia Department of Public Health from "Good to Great". Ms. Allen is a past advisory board member of the STD/HIV Prevention Training Center at John Hopkins University. Ms. Allen is the incoming Chair-Elect of the Board of Directors for the National Coalition of STD Directors. Ms. Allen's work has been recognized by several institutions. She has received the Leadership in Health Award by the Greater Atlanta National Pan Hellenic Council, the Gerald Ludd Lifetime Award for Excellence in Support of HIV/AIDS and Community Service by the (NAESM) National Aids Education and Services for Minorities, Inc, and the 2014 Janet Stancliff Epidemiology Award from the Georgia Public Health Association. She was also the recipient of the first annual Brenda Fitzgerald Leadership award from the Georgia Department of Public Health. Ms. Allen has presented at several national conferences including the National STD Conference, the HIV Prevention Leadership Conference, and the American Public Health Association Conference. Ms. Allen continues to dedicate her heart and passion to Public Health. A native of Atlanta and proud "Georgia Peach", Ms. Allen is a distinguished alum of Georgia Southern University and a member of Sigma Gamma Rho Sorority Inc. She and her husband, Tony live in metro-Atlanta.

As Deputy Commissioner of the Chicago Department of Public Health’s STI/HIV Services Bureau for three years, Ms. Benbow was responsible for ensuring that federal and local prevention, care and housing dollars were used in the most effective way to decrease the burden of STIs and HIV in the city. An important means for achieving this overarching goal is to fund and implement evidence-based interventions that address Chicago’s STI and HIV epidemics. Close collaboration with local research partners on intervention design and evaluation ensures that our combined expertise and resources will inform and strengthen the local STI/HIV strategy. Ms. Benbow is now at Northwestern University Feinberg School of Medicine as Senior Policy Advisor for the Center for Prevention Implementation Science (Ce-PIM) and the Third Coast Center for AIDS Research, where she continues to foster academic/public health partnerships.

Thomas Bertrand, MPH, is the Chief of the Center for HIV, STDs, Hepatitis, and TB at the Rhode Island Department of Health. During his twenty years in public health, Tom was the Executive Director of AIDS Project Rhode Island and the STD Director for the Massachusetts Department of Public Health. Tom has an undergraduate degree in biology from Vassar College and a masters in public health in epidemiology from the State University of New York at Albany.

Jeffrey B. Caballero, MPH is the Executive Director of AAPCHO, an organization dedicated to promoting advocacy, collaboration, and leadership that improves the health status and access of Asian Americans (AAs), Native Hawaiians (NHs) and Pacific Islanders (PIs). AAPCHO envisions a world in which AAs, NHs, PIs, and all communities have equitable access to affordable, high quality, and culturally and linguistically proficient health care. As Executive Director, Jeff oversees AAPCHO’s overall strategic direction and execution of its mission and vision. Jeff has been with AAPCHO since 1993. In this role, he advocates for programs and policies that increase access to high-quality, comprehensive health care services that are culturally and linguistically appropriate; and reduce health inequities. Jeff is currently founding Co-Chair of Hep B United, Advocacy Committee member of the American Diabetes Association, founding member of the Protecting Immigrant Families Coalition, and founding member of the TB United community engagement network. Jeff received his bachelor’s degree in Biochemistry/Cell Biology from the University of California, San Diego, and his Masters in Public Health from the University of California, Los Angeles

Pedro is a doctoral student in Community Health and Health Policy at the CUNY School of Public Health. He also served as the Director of Population Health at Callen-Lorde Community Health Center for 7 years. Currently, Pedro serves as the Clinical Data Scientist at the National Association of Community Health Centers. His work focuses on initiatives that can bridge the gap between social determinants of health and health outcomes. In 2016. Pedro was awarded the Joep Lange and Jacqueline van Tongeren Prize for young investigators by the International AIDS Society for his work on implementation research and PrEP.

Before serving as Vice President for Research and Evaluation at Public Health Solutions, a New York City non-profit, from 1999 to 2018, Dr. Chiasson served for fourteen years in various capacities at the New York City Department of Health including nine years as an Assistant Commissioner of Health with scientific and administrative responsibility for AIDS Surveillance, HIV/AIDS Research, and Vital Statistics and Epidemiology. Her research interests and expertise include the epidemiology of HIV and STIs, women's reproductive health, and obesity. Since 2001, her HIV/STI related research has focused on the relationship between the Internet and high risk sexual behavior among men who have sex with men (MSM) and how the Internet and other digital media can be harnessed for delivery of HIV prevention interventions. Dr. Chiasson is a Professor of Clinical Epidemiology (in Medicine) at Columbia University Mailman School of Public Health.

Dr. Douglas is the former Executive Director of the Tri-County Department of Health, where he oversaw infectious disease programs for the Denver area. He also has served as Director of STD Control and Medical Director of the Denver STD Prevention Training Center, and is a professor at the University of Colorado Health Sciences Center. Beyond is work in Colorado, he is a former Director of the CDC’s Division of STD Prevention. Dr. Douglas is a recognized expert the field of STD prevention, having published over 150 scientific manuscripts or reports. His professional memberships include the Infectious Diseases Society of America, the American STD Association, the American Social Health Association, the American College of Physicians, the American Public Health Association, and the American Society of Microbiology.

Daniel D. Driffin served as Co-Chair of the Fulton County Task Force on HIV/AIDS and Co-founder of THRIVE Support Services, Inc., a patient-advocacy and social support network based in Atlanta, GA offering resources to close to 1,000 Black gay, bisexual and same-gender loving men living with HIV to achieve better health equity. Driffin holds a Master of Public Health from Morehouse School of Medicine with a focus on identifying and curating community-driven innovative solutions to improve health outcomes among men of color. Mr. Driffin’s work and study seeks to improve viral suppression rates in the Deep South and elevate meaningful involvement of those most affected to find solutions that will reduce persistent disparities among men of color living with HIV.

Dr. Gregory “Grey” Felzien (they/them) received their medical degree from the University of Colorado School of Medicine, went on to complete their internship and residency at Vanderbilt University and pursued further fellowship training in infectious diseases at the Medical University of South Carolina. They hold board certification in both internal medicine and infectious diseases and is certified as an American Academy of HIV specialist. Dr. Felzien has had a wide range of experience throughout their career working in the University setting, private practice, Indian Health Services and public health. Their experience has ranged from out- & in-patient care, directorships and administrative duties (co- and acting chief of staff, ICU director, co-infection control director, etc.), research, and publishing papers and book chapters. In 2017, Dr. Felzien was the second editor and coauthor on a book entitled HIV/AIDS in Rural Communities: Research, Education, and Advocacy. https://www.springer.com/us/book/9783319562384 Dr. Felzien is the medical director within Positive Impact Health Center, Inc. here in Georgia. Dr. Felzien continues to work closely with multiple local and national collaborative partners and is actively involved in the rural community through coordinating HIV awareness and education and writing and speaking at the local, state, and national level. Outside of their medical duties, Dr. Felzien is a potter and a University of Georgia certified and Cornell University Master certified beekeeper.

Preeti Pathela has been with the New York City Department of Health and Mental Hygiene’s Bureau of Sexually Transmitted Infections for 16 years. As the Director of Research and Evaluation, she oversees a unit comprising analysts who examine data on STI/HIV patterns among the program’s sexual health clinic population, as well as at the citywide level, to generate and answer research questions around STI/HIV risk and prevention. Their work is frequently used to plan for resource allocation and guide programmatic action. She leads/consults on analyses of both local and multi-jurisdictional data for contribution to the scientific literature. Preeti serves as Member-at-large on the Board of the American STD Association. She received her Doctor of Public Health degree in Epidemiology from the Johns Hopkins Bloomberg School of Public Health and her MPH from Emory University.

Marco currently serves as lead data scientist at the NYC Department of Health & Mental Hygiene. He is interested in advancing applied research of public health relevance and has a strong background in statistical analysis, quantitative research methodology, database design, and data quality management. He has experience working with academic institutions, government agencies, non-profit organizations, and with diverse communities.

Coming Soon!

Ronald O. Valdiserri is a Professor in the Department of Epidemiology, Rollins School of Public Health, Emory University. Prior to joining the faculty at Emory, he served as Senior Research Associate and Distinguished Scholar in the Department of Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health (2016-2019). Dr. Valdiserri’s career in public health includes 26 years of federal service in senior leadership positions at the U.S. Centers for Disease Control and Prevention, the U.S. Department of Veterans Affairs and the Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services (DHHS). From June 2010 through December 2015 he served as the Deputy Assistant Secretary for Health, Infectious Diseases (DHHS); in that position he was responsible for oversight of the National HIV/AIDS Strategy and the National Viral Hepatitis Action Plan. In addition to developing national policies and programs to control HIV, other sexually transmitted infections, tuberculosis and viral hepatitis, he has published numerous scholarly articles on public health policy and practice and has authored/edited four academic texts related to HIV and LGBT health.

Physician-scientist trained in epidemiology, with a specialty in internal medicine and subspecialty in infectious diseases. An award-winning author of more than 150 scholarly publications; serves as a peer reviewer for numerous scientific journals and is an associate editor for the journals International Journal of Tuberculosis and Lung Disease and Emerging Infectious Diseases. A native Puerto Rican, Dr. Castro speaks fluent Spanish, and has frequently served as advisor to the Puerto Rico Department of Health, the Pan American Health Organization, World Health Organization, and several Ministries of Health in countries where TB and HIV constitute major public health problems. In 2008 Dr. Castro was recognized by the Hispanic Officers Advisory Committee, U.S. Public Health Service Commissioned Corps with the prestigious Juan Carlos Finlay award. In October 22, 2011, he was profiled in The Lancet as a “Public Health Hero” by Associate Editor Pamela Das. In March 2014 he received the Lifetime Achievement Award from the International Union Against Tuberculosis and Lung Diseases, North America Region, and the Lifetime Achievement Award conferred by the U.S. Agency for International Development. In June 2016 he received the prestigious CDC Charles C. Shepard Lifetime Science Achievement Award. "This award recognizes individuals for a body of work contributing to public health."

Jeffrey S. Crowley, MPH is a Distinguished Scholar and Program Director of Infectious Disease Initiatives at the O’Neill Institute for National and Global Health Law at Georgetown Law. He also serves as an adjunct professor of law. From 2009 to 2011, he served as the Director of the White House Office of National AIDS Policy and Senior Advisor on Disability Policy. As President Obama’s chief HIV/AIDS advisor, Mr. Crowley led the development of the first comprehensive National HIV/AIDS Strategy for the United States. From 2000 to 2009, he was a Senior Research Scholar at Georgetown University's Health Policy Institute and subsequent to its founding, a Senior Scholar at the O'Neill Institute focusing his work on improving health care for people with HIV and other disabilities and chronic conditions through improvements to Medicaid and Medicare. Mr. Crowley also served in senior positions at the National Association of People with AIDS from 1994 to 2000. In September 2019, he was appointed to the National Academy of Sciences, Engineering and Medicine Committee on the Prevention and Control of Sexually Transmitted Infections in the United States.

In 1995 James W. Curran was appointed professor of epidemiology and dean of the Rollins School of Public Health.

Graduating from the University of Notre Dame, he received his MD from the University of Michigan and a master of public health from Harvard University. In 1981 Dr. Curran coordinated the task force on acquired immune deficiency syndrome (AIDS) at the Centers for Disease Control and Prevention (CDC) and then led the HIV/AIDS Division. While at the CDC, he attained the rank of the assistant surgeon general.

Dr. Curran is a fellow of the American Epidemiologic Society, the American College of Preventive Medicine, and the Infectious Diseases Society of America. Author or co-author of more than 290 scholarly publications, he was elected to the Institute of Medicine of the National Academy of Sciences in 1993. He was given the Surgeon General's Medal of Excellence in 1996 and the John Snow Award from the American Public Health Association in 2003.

Dr. Curran is an adjunct Professor of Medicine and Nursing, and Co-Director of the Emory Center for AIDS Research. He is immediate past chair of the board on Population Health and Public Health Practice of the Institute of Medicine and serves on the Board of Directors of the Association of Schools and Programs of Public Health. Additionally, he holds an endowed chair known as the James W. Curran Dean of Public Health.

Dr. Douglas is the former Executive Director of the Tri-County Department of Health, where he oversaw infectious disease programs for the Denver area. He also has served as Director of STD Control and Medical Director of the Denver STD Prevention Training Center, and is a professor at the University of Colorado Health Sciences Center. Beyond is work in Colorado, he is a former Director of the CDC’s Division of STD Prevention. Dr. Douglas is a recognized expert the field of STD prevention, having published over 150 scientific manuscripts or reports. His professional memberships include the Infectious Diseases Society of America, the American STD Association, the American Social Health Association, the American College of Physicians, the American Public Health Association, and the American Society of Microbiology.

Robert Greenwald is a Clinical Professor of Law at Harvard Law School and the faculty director of the Law School's Center for Health Law and Policy Innovation (CHLPI). In addition to teaching seminars in health and public health law and policy, for over 25 years Robert has been engaged in state and national research, policy development, and advocacy to expand access to high-quality health care, reduce health disparities, and promote more equitable and effective health care systems.

Robert is currently serving as a co-chair of the Federal Chronic Illness & Disability Partnership and the HIV Health Care Access Working Group. From 2000-2006, Robert served as member of the Presidential Advisory Council on HIV/AIDS and as the co-chair of its Access to Care sub-committee. Robert has served as a consultant to the federal government’s Health Resources Services Administration and the Centers for Disease Control and Prevention's Community Advisory Board as well as numerous state governments and community-based organizations. Robert received his B.A. from Vassar College in 1980 and his J.D. from Northeastern University School of Law in 1986.

David Holtgrave, Ph.D., is on leave from the University at Albany School of Public Health while performing federal service. In his current efforts, Dr. Holtgrave focuses on public health policy needs as they relate to data, evidence, and equity at a national level. Prior to this position, he served as the Dean of the School of Public Health, University at Albany, State University of New York. He has also been appointed as a SUNY Empire Innovation Professor and a SUNY Distinguished Professor.

From August 2005 through February 2018, David served as Professor and Chair of the Department of Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health. In July, 2017, he was appointed to hold the Inaugural Health, Behavior and Society Professorship (an endowed professorship). He also held joint appointments in the Johns Hopkins schools of medicine and nursing.

Dr. Holtgrave has worked extensively in the field of HIV prevention since 1991. His research has focused on the effectiveness and cost-effectiveness of HIV prevention interventions and the translation of those study findings to HIV prevention policy. Dr. Holtgrave previously served as member and then vice-chair of the Presidential Advisory Council on HIV/AIDS during President Obama's Administration, and testified before the U.S. House of Representatives during Representative Henry Waxman's hearing on domestic HIV prevention in 2008.

Prior to his position at Johns Hopkins University, Dr. Holtgrave was a professor at the Rollins School of Public Health at Emory University. He also served as director of the Division of HIV/AIDS Prevention-Intervention Research and Support at the U.S. Centers for Disease Control and Prevention (CDC), as well as on the faculty at the Center for AIDS Intervention Research at the Medical College of Wisconsin. He has authored or co-authored over 300 professional publications. He edited The Handbook of Economic Evaluation of HIV Prevention Programs (Plenum Press, 1998). Along with a number of colleagues from AIDS United and Johns Hopkins University, he is a co-author of the book, "Improving Access to HIV Care: Lessons from Five U.S. Sites" (Johns Hopkins University Press, https://jhupbooks.press.jhu.edu/content/improving-access-hiv-care).

Jesse Milan, Jr., a tireless community advocate and nationally recognized expert on HIV/AIDS policies and programs, joined AIDS United in June 2016 as interim president and CEO and assumed the permanent position on November 28, 2016.

A person living with HIV for over three decades, Milan is a recognized leader in the HIV community. He brings 30-years of experience in executive roles in the public and private sectors and has directed multi-million dollar budgets and staff for federal, state, local and global public health agencies. Notably, beginning in 2002 he served a five-year appointment as co-chair of the Centers for Disease Control and Prevention (CDC)/Health Resources and Services Administration (HRSA) Advisory Committee on HIV and STD Prevention and Treatment (CHAC) and in 2007 was designated a Fulbright Senior Specialist in Global HIV/AIDS.

Most recently, Milan has been working as both a leadership development consultant with the Dorrier Underwood firm, and as a subject matter expert consultant for clients including the CDC, NMAC, HRSA and the Office of HIV/AIDS and Infectious Disease Policy, within the Office of the Assistant Secretary of Health. Further, he currently serves as Chair Emeritus on the Black AIDS Institute board of directors, on the Scientific Advisory Board for the President’s Emergency Plan for AIDS Relief (PEPFAR) and on the Dean’s Advisory Council for the UNC Gillings School of Global Public Health.

A lawyer by background, Milan has received numerous honors including the 2015 Public Service Award from the Association of Nurses in AIDS Care (ANAC) and was awarded the HRSA’s HIV/AIDS Bureau Administrator’s Award for his leadership in the global fight against HIV.

He has addressed millions on television and radio, has given hundreds of presentations and workshops, and represented the U.S. State Department on three international speaking tours to seven African nations. He has been an inspiring keynote speaker at national and regional conferences and events including at the White House.

“I love working with people and groups devoted to changing the trajectory of HIV/AIDS,” said Milan. “I have admired AIDS United since its founding and believe in the pivotal role it plays in our nation’s response to the HIV epidemic.”

Gregorio Millett is a well-published and nationally recognized epidemiologist/researcher with significant experience working at the highest levels of federal HIV policy development at both the White House and the Centers for Disease Control and Prevention (CDC). From 2009 to 2011, Mr. Millett served as a detailee in the White House Office of National AIDS Policy as a Senior Policy Advisor. In this role, he coordinated the Office’s policy and research activities, including HIV prevention policy and the federal-level inter-agency process to develop the National AIDS Strategy. Gregorio Millett is one of three principal writers of President Obama’s National HIV/AIDS Strategy. He served on the organizing committee for the Washington, DC, Conference, and was the federal lead in organizing the U.S. government and White House activities around the 2012 International AIDS Conference. Mr. Millett also worked on a diverse array of policy issues during his tenure at the White House, including the elimination of the HIV entry ban that prohibited HIV-positive persons from travelling to or seeking residency in the United States; the temporary suspension of the ban prohibiting federal funding for domestic or global needle exchange programs; and the reallocation of HIV prevention resources by CDC to adopt a new funding formula for state and local health departments that better aligns funding with current disease burden.

Prior to joining amfAR in May 2014, Mr. Millett served as the HHS/CDC Liaison to the White House Office of National AIDS Policy. Mr. Millett has been credited with changing the underlying assumptions among researchers of observed HIV infection disparities among black men who have sex with men (MsM) and is widely recognized as one of the first researchers to show no protective effect associated with male circumcision for MSM. Highlighting these accomplishments, Mr. Millett was honored with a scientific profile in the prestigious medical journal The Lancet in 2012 and he published two well-cited studies in The Lancet that same year. Mr. Millett has published over 40 peer-reviewed research papers in leading, health policy and public health journals such as Journal of the American Medical Association, AIDS, American Psychology, and Health Affairs. He also co-authored a health policy paper with Dr. Anthony Fauci, former Surgeon General of the United States Dr. Regina Benjamin, CDC Director Dr. Thomas Frieden and the Assistant Secretary of Health Dr. Howard Koh. Mr. Millett’s research has been covered in major media outlets such as Time magazine, The New York Times, The Washington Post, and The Wall Street Journal.

Mr. Millett has a Bachelor of Arts degree from Dartmouth College and a Master of Public Health degree from the University of North Carolina at Chapel Hill.